110 Days
Source:
وكالة الأنباء القطرية
WHO launches Ebola drug trials in DRC
The World Health Organization has launched a clinical trial in the Democratic Republic of the Congo to evaluate the effectiveness of two potential treatments for the Bondo Pugo virus that causes Ebola. The treatments under investigation include a monoclonal antibody and an antiviral drug. The study is being conducted with support from the National Institute of Biomedical Research and partners, amid an outbreak resulting in 438 deaths and 1,406 cases since May, with a case fatality rate of 31.2%.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)